ARMGO Pharma Revenue and Competitors
Estimated Revenue & Valuation
- ARMGO Pharma's estimated annual revenue is currently $852.5k per year.
- ARMGO Pharma's estimated revenue per employee is $77,500
Employee Data
- ARMGO Pharma has 11 Employees.
- ARMGO Pharma grew their employee count by 0% last year.
ARMGO Pharma's People
| Name | Title | Email/Phone |
|---|
ARMGO Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is ARMGO Pharma?
ARMGO Pharma Inc., is a privately held biopharmaceutical company dedicated to applying original, targeted science to the discovery and development of novel small-molecule therapeutics to treat debilitating cardiac, musculoskeletal, and neurological disorders. The company's proprietary drugs, known as Rycals®, are a new class of oral agents that repair calcium leaks through the Ryanodine Receptor (RyR). ARMGO Pharma has been awarded an exclusive, worldwide license from Columbia University for its RyR technology based on the research of founding scientist Andrew R. Marks, M.D.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$852.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Ardsley
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 17 | -55% | N/A |
#2 | $5.8M | 32 | -6% | N/A |
#3 | $9.5M | 44 | 42% | N/A |
#4 | $14.2M | 79 | -96% | N/A |
#5 | $20.5M | 114 | 5% | N/A |